Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc.

Overview
Date Founded

1960

Headquarters

81 Wyman Street Waltham, Massachusetts, 02454, United States

Type of Company

Public

Employees (Worldwide)

70K

Industries

Industrial Machinery & Manufacturing
Wholesale: Industrial Products & Manufacturing
Medical Products & Equipment
Hospitals & Patient Services
Computer Software
Biotechnology

Company Description

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Contact Data
Trying to get in touch with decision makers at Thermo Fisher Scientific, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Senior Vice President & Chief Financial Officer

Executive Vice President & Chief Operating Officer

Senior Vice President & General Counsel

Chief Scientific Officer

Chief Accounting Officer

Chief Human Resources Officer & Senior Vice President

Vice President & General Manager

Senior Vice President & President-EMEA

Senior Vice President & President, Customer Channels

Board of Directors

Chairman at Stonegate Capital LLC

Chief Financial Officer at Uber Technologies, Inc.

Co-President at Thomas H. Lee Partners LP

Former Executive Vice President & Chief Financial Officer at Merck & Co., Inc.

Former President & Chief Executive Officer at Novo Nordisk A/S

Chairman & Chief Executive Officer at Deutsch Engineered Connecting Devices Corp.

Chief Business Officer at University of Texas at Austin - Dell Medical School

President & Chief Executive Officer at HP, Inc.

Director at The David H. Koch Institute for Integrative Cancer Research

Chief Executive Officer at DPx Holdings BV

Paths to Thermo Fisher Scientific, Inc.
Potential Connections via
Relationship Science
You
Thermo Fisher Scientific, Inc.
Owners & Shareholders
Details Hidden

MFS Investment Management utilizes various investment techniques to implement its investment strategies, including, but not limited to, long and short-term purchases, short sales, margin transactions, options, and exchange-traded and over-the-counter derivatives or other methods to seek to achieve performance. They employ a variety of methods to evaluate securities, including fundamental and quantitative analysis. MFS Investment Management offers fundamental, active and research-driven equity strategies that strive for less volatility relative to benchmarks and greater value through changing markets. Fixed income strategy offers total return focused and credit oriented approach. Multi-Asset strategy is goal-oriented, diversified and disciplined investment approach that combines broad diversification across multiple asset classes, active asset allocation, and bottom-up security selection. MFS' retirement solutions are designed with a goal of maximizing growth and supporting income over a lifetime by focusing on long-term returns. MFS Blended Research is an approach to active equity management that combines the firm's fundamental research expertise with highly systematic quantitative research.

Details Hidden

CWI employs a long-term, value-oriented global investment approach and a multiple portfolio manager system that combines teamwork and individual accountability. The firm is committed to maintaining low operating expenses, among the lowest in the fund industry. They utilize fundamental research to gather in-depth information on markets and companies around the world. CWI employs a security-by-security approach to portfolio construction and emphasize long-term investments. Their strategies focus on determining the difference between the fundamental value of a company and its price in the marketplace. CWI offers a wide variety of equity, fixed-income and balanced investment strategies. Their strategies are categorized as global, multi-regional and regional investment strategies.

Details Hidden

Capital World Global Investors (CWGI) is the investment adviser to the American Funds Group, a family of 30 funds marketed to individuals exclusively through financial advisers and other intermediaries. American Funds are also used as investment vehicles for 401ks, other retirement plans, variable annuities and 529 college savings plans. The funds have the following characteristics: (1) a long-term, value-oriented approach (2) long-established, global research (3) a multiple portfolio counselor system that combines teamwork with individual accountability (4) experienced, long-tenured investment professionals and (5) a commitment to low operating expenses, among the lowest in the fund industry. CWGI uses a Multiple Portfolio Counselor System. The assets of each fund are divided into smaller, more manageable portions. Each portion is managed by a portfolio counselor who operates autonomously, investing his or her portion as though it were an entire fund (subject to fund objectives and overall guidelines). Research analysts typically manage a segment as well, bringing their expertise directly to bear on the fund's results. Portfolio counselors are free to make their own decisions. As a fund's assets grow, new counselors can be added. Investment decisions are based on internal research. Equity research is comprehensive and bottom-up while at the same time constantly monitoring broader economic, political, currency and interest rate trends. Investment research is proprietary and used solely by CWGI portfolio managers.

Recent Transactions
Details Hidden

Thermo Fisher Scientific, Inc. purchases Brammer Bio LLC from Ampersand Management LLC

Details Hidden

Kohlberg Kravis Roberts & Co. LP, PHC Holdings Corporation purchase Thermo Fisher Scientific, Inc. /Anatomical Pathology Business from Thermo Fisher Scientific, Inc.

Details Hidden

Thermo Fisher Scientific, Inc. purchases Gatan, Inc. from Roper Technologies, Inc.

Insider Transactions
Details Hidden
Transaction Advisors
Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Investment Advisor

Advised onThermo Fisher Scientific, Inc. purchases Patheon NV from JLL Partners, Inc.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Legal Advisor

Advised onKohlberg Kravis Roberts & Co. LP, PHC Holdings Corporation purchase Thermo Fisher Scientific, Inc. /Anatomical Pathology Business from Thermo Fisher Scientific, Inc.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Life Technologies Corp.

Advisors & Consultants
Legal Advisor

Partner at Paul, Weiss, Rifkind, Wharton & Garrison LLP

Legal Advisor

Partner at Covington & Burling LLP

Advisor

President at Shaker Recruitment Advertising & Communications, Inc.

Clients

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.

Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Stoughton, MA.

Key Stats and Financials As of 2018
Market Capitalization
$119B
Total Enterprise Value
$108B
Earnings Per Share
$7.24
Revenue
$24.4B
Total Equity
$27.6B
Total Debt
$19B
Net Profit
$2.94B
EBITDAMargin
25.2%
Enterprise Value Sales
4.42x
Enterprise Value EBITDAOperating
17.55x
TEVNet Income
36.67x
Debt TEV
0.18x
EBITDA
$6.14B
Five Year Compounded Annual Growth Rate Of Revenue
13.22%
Three Year Compounded Annual Growth Rate Of Revenue
12.81%
Non-Profit Donations & Grants
$5,000 - $10K
2012
Non-Profit Donations & Grants Received
Investments
Details Hidden

EOS Biotechnology, Inc., part of PDL BioPharma, Inc., is an American company located in San Francisco, CA, that develops therapeutic and diagnostic drugs. It was founded by Richard Murray, David W. Martin and David H. Mack. On 07 Apr 03 Protein Design Labs, Inc. acquired EOS Biotechnology, Inc. for $32.52 million.

Investors
Details Hidden

Venture Partner at LaunchCapital LLC

Suppliers
Luminex Corp. Medical Support Services | Austin, TX

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.

Deutsche Post AG Other Business & Consulting Services | Bonn, NW

The Deutsche Post and DHL corporate brands offer a one-of-a-kind portfolio of logistics and communications services. The Group provides its customers with both easy to use standardized products as well as innovative and tailored solutions ranging from dialog marketing to industrial supply chains. About 475,000 employees in more than 220 countries and territories form a global network focused on service, quality and sustainability. With programs in the areas of climate protection, disaster relief and education, the Group is committed to social responsibility.

Response Biomedical Corp. Other Business & Consulting Services | Vancouver, BC

Response Biomedical Corp. engages in the research, development, commercialization, and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing, and on-site environmental testing markets. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company was founded by William Joseph Radvak on August 20, 1980 and is headquartered in Vancouver, Canada.

Awards & Honors
Rank #164
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #164
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thermo Fisher Scientific, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thermo Fisher Scientific, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Thermo Fisher Scientific, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/thermo-fisher-scientific-inc-743931
  • https://relationshipscience.com/organization/thermo-fisher-scientific-inc-743931